121 related articles for article (PubMed ID: 4471024)
1. Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo.
Strander H; Cantell K
In Vitro Monogr; 1974; (3):49-56. PubMed ID: 4471024
[No Abstract] [Full Text] [Related]
2. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
3. Interferons in oncology.
Woll PJ; Pettengell R
Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory investigations on man: systemic administration of potent interferon to man.
Strander H; Cantell K; Carlström G; Jakobsson PA
J Natl Cancer Inst; 1973 Sep; 51(3):733-42. PubMed ID: 4355215
[No Abstract] [Full Text] [Related]
5. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
6. [Antineoplastic effects of interferons].
Shimoyama M
Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409
[No Abstract] [Full Text] [Related]
7. Interferon: anticancer agent having multifarious activity.
Yabrov AA
Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
[No Abstract] [Full Text] [Related]
8. Interferon: a new name in cancer treatment.
Lancaster J
Nurs RSA; 1987 Feb; 2(2):28-9. PubMed ID: 2438555
[No Abstract] [Full Text] [Related]
9. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of interferon action.
Schwarz LA; Fleischmann WR
Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
[TBL] [Abstract][Full Text] [Related]
11. Interferons as antitumor agents.
Taylor S
J Kans Med Soc; 1981 Mar; 82(3):128-30, 138. PubMed ID: 6168716
[No Abstract] [Full Text] [Related]
12. [Interferons in cancerology. Focus in 1988].
Boiron M
Pathol Biol (Paris); 1989 Feb; 37(2):92-3. PubMed ID: 2652080
[No Abstract] [Full Text] [Related]
13. On the mechanisms of the antitumor effects of interferon.
Gresser I
Tex Rep Biol Med; 1981-1982; 41():582-9. PubMed ID: 6189223
[No Abstract] [Full Text] [Related]
14. [The Rubenosticon test in hematologic and lymphoreticular diseases].
Milejski P; Nowicka J; Masiak M; Orzechowska-Juzwenko K; Kotlarek-Haus S
Pol Tyg Lek; 1984 Jun; 39(24):815-8. PubMed ID: 6494040
[No Abstract] [Full Text] [Related]
15. Laboratory diagnosis of rubella virus infections.
Iwakata S; Rhodes AH; Labzoffsky NA
Can Med Assoc J; 1973 Apr; 108(7):894-5 passim. PubMed ID: 4581796
[No Abstract] [Full Text] [Related]
16. [Mechanisms of the antitumor effects interferons].
Adam Z
Vnitr Lek; 1994 Jan; 40(1):56-8. PubMed ID: 7511261
[TBL] [Abstract][Full Text] [Related]
17. The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status.
Lennette EH; Schmidt NJ; Magoffin RL
J Immunol; 1967 Oct; 99(4):785-93. PubMed ID: 4860926
[No Abstract] [Full Text] [Related]
18. Usages of interferon and interferon inducers in man: the second half of 1980.
Pollard RB
Med Biol; 1981 Apr; 59(2):69-76. PubMed ID: 6171689
[No Abstract] [Full Text] [Related]
19. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
20. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
Lee SH; Kelley S; Chiu H; Stebbing N
Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
